X4 Pharmaceuticals, Inc.

NASDAQ:XFOR

0.8039 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q1
Omzet 0.560.56303.0600000000000000300003.5000000000
Kosten van de omzet 0.2270.2680.0620.0620.5020.5160.5120.5010.4940.50.4990.4940.4910.4870.42000000000000000000.1
Brutowinst 0.3330.295-0.0622.998-0.502-0.516-0.512-0.501-0.494-0.5-0.499-0.494-0.491-0.487-0.42000300003.500000000-0.1
Brutowinstmarge 0.5950.52400.9800000000000100100001000000000
Onderzoek- en ontwikkelingskosten 19.17320.91419.79215.2119.08115.60115.60122.06319.01413.82114.11312.16213.18813.19312.10412.29811.3819.3428.9117.0658.5898.8545.6554.3449.5728.938.1339.2310.6013.9064.3914.2272.529
Algemene en administratieve kosten 000000014.41314.4136.7497.6647.1355.9315.8045.8325.3575.5995.3164.673.9144.3834.564.7838.6283.2753.6862.8172.3762.4551.7381.4361.4730
Verkoop- en marketingkosten 0000000-7.172-7.85000000000000000000000000
Verkoop-, algemene en administratieve kosten 15.6613.27817.4359.9278.13310.20410.2047.2416.5636.7497.6647.1355.9315.8045.8325.3575.5995.3164.673.9144.3834.564.7838.6283.2753.6862.8172.3762.4551.7381.4361.4731.24
Overige kosten 000.1050.2120.017-29.892-29.8925.288-3.513-0.0590.06-1.149-0.074-0.6350.186-0.7450.228-0.4860.0410.0380.0520.1490-0.006-0.0060.001-0.074-0.0730.086-0.028-0.0010.0160
Bedrijfskosten 34.83333.99837.22725.13727.21425.80525.80529.30425.57720.5721.77719.29719.11918.99717.93617.65516.9814.65813.58110.97912.97213.41410.43812.7710.83112.110.50510.91811.4384.7825.1275.1393.769
Bedrijfsresultaat -34.571.103-37.289-25.199-27.214-25.805-25.805-22.907-25.577-20.57-21.268-29.055-19.119-18.997-17.936-17.655-16.98-14.658-10.581-10.875-16.976-13.414-10.438-9.472-12.847-12.616-10.95-11.606-13.056-5.644-5.827-5.7-3.869
Bedrijfsresultaat ratio -61.607126.2930-8.23500000000000-5,885,000,000,00000-3.5270000-2.706000000000
Totaal overige inkomsten en kosten netto -2.18119.748-14.4586.10224.935-29.8925.288-3.513-1.445-0.638-0.674-1.149-1.054-0.635-0.734-0.745-0.469-0.486-0.4090.038-0.7380.031-0.4350.1141.9470.4830.320.4191.456-0.0610.4420.3790.369
Inkomen voor belasting -36.68190.851-51.747-19.097-2.279-55.697-55.697-24.016-29.09-21.208-21.942-30.204-20.173-19.632-18.67-18.4-17.449-15.144-10.99-10.837-17.714-13.383-10.873-9.358-10.9-12.133-10.63-11.187-11.6-5.705-5.385-5.321-3.5
Inkomen voor belasting ratio -65.502161.3690-6.24100000000000-6,133,333,333,333.33300-3.6630000-2.674000000000
Belastingkosten 0.0150.0180.0190.0330.0260.0150.0150.0040.0140.0040.0230.0030.0020.0060.00600.925-0.0660.148-0.1360.740.6610.3990.2480.2530.260.1930.2430.4290.4161.0180.8080
Nettowinst -36.69690.833-51.766-19.13-2.305-55.712-55.712-24.02-29.104-21.212-21.965-30.207-20.175-19.638-18.676-18.4-17.449-15.144-11.138-10.837-17.714-13.383-10.873-9.358-10.9-12.133-10.63-11.187-11.6-5.705-5.385-5.321-3.5
Nettowinstmarge -65.529161.3370-6.25200000000000-6,133,333,333,333.33300-3.7130000-2.674000000000
WPA (Winst Per Aandeel) -0.180.45-0.26-0.096-0.012-0.33-0.38-0.24-0.29-0.6-0.65-1.04-0.76-0.74-0.9-0.91-0.87-0.76-0.56-0.66-1.22-1.02-6.33-5.45-4.57-5.09-4.46-10.09-6.43-6.15-5.8-5.73-8.81
Verwaterde WPA -0.180.45-0.26-0.096-0.012-0.33-0.38-0.24-0.29-0.6-0.65-1.04-0.76-0.74-0.9-0.91-0.87-0.76-0.56-0.66-1.22-1.02-6.33-5.45-4.57-5.09-4.46-10.09-6.43-6.15-5.8-5.73-8.81
EBITDA -34-33.703-49.811-17.149-0.143-54.033-22.395-27.445-20.154-19.79-20.53-28.785-19.059-18.24-17.359-17.552-16.834-14.391-10.37-10.104-16.999-12.847-10.454-9.07-10.605-11.835-10.317-10.772-11.295-5.213-4.318-4.479-3.769
EBITDA ratio -60.714-59.8630-8.21500000000000-5,885,000,000,00000-3.4030000-2.591000000000